Avecia Pharmaceuticals Limited
Records under this name other than patents Avecia Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Avecia Pharmaceuticals Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,828,902 | Microencapsulated catalyst methods of preparation and method of use thereof Formerly held Term ended Term ended May 23, 2023 · High confidence | Term ended | Term ended May 23, 2023 | High confidence |
| US 6,897,262 | Scavenger resin and processes for the use thereof Formerly held Term ended Term ended Aug 2, 2021 · USPTO record | Term ended | Term ended Aug 2, 2021 | USPTO record |
| US 6,372,931 | Transfer hydrogenation process and catalyst Formerly held Term ended Term ended Nov 9, 2019 · USPTO record | Term ended | Term ended Nov 9, 2019 | USPTO record |
| US 9,024,025 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin Formerly held Lapsed on the fee record Ended May 5, 2019 · USPTO record | Lapsed on the fee record | Ended May 5, 2019 | USPTO record |
| US 8,703,945 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin Formerly held Lapsed on the fee record Ended Apr 22, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 22, 2018 | USPTO record |
| US 6,545,188 | Transfer hydrogenation process and catalyst Formerly held Term ended Term ended Mar 20, 2018 · USPTO record | Term ended | Term ended Mar 20, 2018 | USPTO record |
| US 8,614,335 | Process and intermediates useful in the preparation of statins, particularly atorvastatin Formerly held Lapsed on the fee record Ended Dec 24, 2017 · USPTO record | Lapsed on the fee record | Ended Dec 24, 2017 | USPTO record |
| US 7,414,141 | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin Formerly held Lapsed on the fee record Ended Aug 19, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 19, 2016 | USPTO record |
| US 7,462,731 | Processes for the preparation of heterocyclic hydroxyamines and intermediates and catalysts for use therein Formerly held Lapsed on the fee record Ended Dec 9, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 9, 2012 | USPTO record |
| US 6,696,608 | Transfer hydrogenation process Lapsed on the fee record Ended Feb 24, 2012 · USPTO record | Lapsed on the fee record | Ended Feb 24, 2012 | USPTO record |